EMG1

protein-coding

EMG1 N1-specific pseudouridine methyltransferase, the group of SPOUT methyltransferase domain containing|SSU processome

Gene summary

This gene encodes an essential, conserved eukaryotic protein that methylates pseudouridine in 18S rRNA. The related protein in yeast is a component of the small subunit processome and is essential for biogenesis of the ribosomal 40S subunit. A mutation in this gene has been associated with Bowen-Conradi syndrome. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Feb 2016]

MANE transcript

NM_006331.8

Inheritance

AR

ClinVar variants

P:1U:13B:14

Top phenotype

Bowen-Conradi syndrome

gnomAD constraint

pLI —, LoF o/e 0.71

Max pathogenic AF

—

Genomic locus

chr12:6,970,913-6,979,936

External References & Databases

Transcript & Mutation Effects

hg38 • Region Span ~9.0 kb
Loading mutation effect viewer...

GenCC Phenotypes & Disease Associations

Curated gene-disease validity assertions and inheritance patterns

Bowen-Conradi syndromeLIMITED

Inheritance Pattern: AR

Disease ID:MONDO:0008879

Submitter: Labcorp Genetics (formerly Invitae)

Bowen-Conradi syndromeSUPPORTIVE

Inheritance Pattern: AR

Disease ID:MONDO:0008879

Submitter: Orphanet

Bowen-Conradi syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0008879

Submitter: G2P

Bowen-Conradi syndromeSTRONG

Inheritance Pattern: AR

Disease ID:MONDO:0008879

Submitter: ClinGen

*EMG1* (EMG1 N1-specific pseudouridine methyltransferase) is located on chromosome 12 at position 12p13.31. The protein is key in processing of pre-18S rRNA and small ribosomal subunit formation. *EMG1* was first reported in relation to autosomal recessive Bowen-Conradi Syndrome (BCS) in 2009 (Armistead et al., PMID: 19463982). This condition is characterized by facial anomalies such as micrognathia and prominent nose, joint contractures, congenital microcephaly, rocker bottom foot/clubbed foot, and digit anomalies including camptodactyly. BCS is often lethal within the first year of life due to complications linked to motor issues and poor growth. One variant (missense, p.(Asp86Gly)) that has been reported in 39 probands from 29 nuclear families in the highly consanguineous Hutteritte population, and in one publication, is included in this curation (PMID: 19463982). A founder effect is suspected. The mechanism of pathogenicity appears to be gain-of-function. This gene-disease relationship is also supported by experimental evidence including functional alteration, expression-level evidence, and mouse models (Liu & Thiele, 2001, PMID: 11694595; Eschrich et al., 2001, PMID: 11935223; Wu et al., 2010, PMID: 20858271; Armistead et al., 2015, PMID: 25708872). Functional alteration evidence shows that rRNA processing is inhibited when *EMG1* is mutated. The protein localized to the nucleus in a yeast cell analysis. Mouse models show that the mutants exhibited early embryonic lethality, abnormal expression of early cell lineage markers, increased apoptosis, and neural tube defects.The impact of other variants in *EMG1* is unknown; given the single position (p.Asp86Gly) involved to date, other variants would need very careful consideration. In summary, the classification of this gene-disease relationship was upgraded from moderate to strong based on the strength of evidence, particularly the evidence from the mouse models and the restrictions in scoring founder variants through the framework. This classification was approved by the ClinGen Syndromic Disorders GCEP on the meeting date May 16th, 2025 (SOP Version 11).

Bowen-Conradi syndromeMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0008879

Submitter: PanelApp Australia

Bowen-Conradi syndromeMODERATE

Inheritance Pattern: AR

Disease ID:MONDO:0008879

Submitter: Ambry Genetics

Clinical Genomic Database (CGD)

Bowen-Conradi syndromeAR

Manifestation: Craniofacial; Musculoskeletal; Neurologic

Intervention: General

Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing

Refs: 974244; 484596; 12838567; 15578624; 19463982Source: CGD (NHGRI)

ClinVar Associated Diseases & Phenotypes

Reported disease conditions connected to EMG1 variants in ClinVar

4 Conditions Cataloged
not providedTotal: 12
Inborn genetic diseasesTotal: 9
Bowen-Conradi syndromeTotal: 3
EMG1-related disorderTotal: 2

ClinVar Variants & Pathogenicity by Type

Statistics based on transcript NM_006331.8. Only rare variants are included.

We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.

Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.

EffectPLPVUSLBBSum
synonymous
1
clinvar
6
clinvar
4
clinvar
11
missense
1
clinvar
11
clinvar
3
clinvar
15
nonsense
0
start loss
0
frameshift
1
clinvar
1
clinvar
2
splice donor/acceptor (+/-2bp)
0
Total10139528

Highest pathogenic variant AF is 0.0000043381797

Loading ClinVar variants...

Transcript Catalog

Annotated transcript isoforms across RefSeq and Ensembl databases

Showing 4 of 39 transcripts
Transcript IDSourceProtein IDCoding ExonsMANE Status
NM_006331.8RefSeqNP_006322.46MANE Select
ENST00000599672.6EnsemblENSP00000470560.16MANE Select
NM_001320049.2RefSeqNP_001306978.15Standard
ENST00000539196.2EnsemblENSP00000479546.15Standard

gnomAD Constraint

Source: gnomAD

Gene type
protein_coding
Transcript type
protein_coding
Transcript
ENST00000261406
Coding exons
7
Length
33113
Individuals with no LoFs
124615
Homozygous LoFs
0
Heterozygous LoFs
22
Defined
124637
p
0.0000883
Z-ScoreObservedExpectedObserved/ExpectedMutation RateTotal Possible
Missense-0.3041471371.070.000006991565
Missense (PolyPhen)
Synonymous-1.566449.91.280.00000232488
Loss of Function0.938912.60.7157.84e-7125

Population LoF Frequency

PopulationCAFp-valueStatus
African0.000260.00026rare
Latino/Admixed American00.0absent
Ashkenazi Jewish00.0absent
East Asian0.000170.00017rare
Finnish0.000140.00014rare
European (Non-Finnish)0.0000720.000071rare
South Asian0.000130.00013rare
Other00.0absent
For research and educational, non-commercial use only. Not for clinical or diagnostic use. GeneBe does not provide medical advice. Data use for AI modeling is prohibited: if used, the cost is $0.001 per byte of downloaded uncompressed data.